Sensus Healthcare to Participate in Two Upcoming Investor Conferences on November 30th and December 1st
— Evercore ISI MedTools Investor Conference in Boston, MA — Drexel Hamilton’s Emerging Growth Conference in New York, NY BOCA RATON, Fla., Nov. 16, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy (SRT), […]
Sensus Healthcare Reports Third Quarter 2016 Results
– Q3 revenues increased 58% year-over-year to $3.33 million – Worldwide installed base increased to 256 units BOCA RATON, Fla., Nov. 3, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy (SRT), today reported […]
Sensus Healthcare to Announce Third Quarter 2016 Results on November 3, 2016
BOCA RATON, Fla., Oct. 20, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today announced that it will report its third quarter 2016 financial results on Thursday, November 3, 2016 after the market […]
Sensus Healthcare to Participate in Important Dermatological and Institutional Investor Conferences from October 20th to October 23rd
–2016 Fall Clinical Dermatology Conference in Las Vegas, NV –Dawson James 2016 Small Cap Growth Stock Conference in Jupiter, FL BOCA RATON, Fla., Oct. 6, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy […]
Sensus Healthcare, Inc. Receives the Frost & Sullivan 2016 Global Non-melanoma Skin Cancer Therapy Technology Leadership Award
– Sensus Credited with Advancing Superficial Radio Therapy as Viable Treatment Option for NMSC – BOCA RATON, Fla., Sept. 7, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers (NMSC) and other skin conditions such as keloids with superficial radiation therapy (SRT), announced today it […]
Sensus Healthcare to Sponsor First International Keloid Symposium on September 8 and 9 in New York
BOCA RATON, Fla., Aug. 31, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy (SRT), today announced that the Company will sponsor the First International Keloid Symposium to be held at The Rockefeller University […]
Sensus Healthcare Reports Second Quarter 2016 Results
– Q2 revenues increased 49% year-over-year to $3.6 million – Worldwide installed base increased to 247 units -Successfully completed IPO on June 2nd; cash of $15.8 million, with no debt, at June 30, 2016 BOCA RATON, Fla., Aug. 4, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of […]
Sensus Healthcare to Announce Second Quarter 2016 Results on August 4, 2016
BOCA RATON, Fla., Aug. 2, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS; SRTSW), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today provided a reminder that it will report its second quarter 2016 financial results on Thursday, August 4, 2016 […]
Sensus Healthcare, Inc. Names Anthony Petrelli to its Board of Directors
– Over 40 Years in Investment Banking – Extensive Regulatory and Securities Advisory Experience BOCA RATON, Fla., Aug. 2, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today announced the appointment of Anthony […]
Sensus Healthcare, Inc. Units Separate; Trading of Common Stock and Warrants Commences
BOCA RATON, Fla., July 25, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTSU), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today reported the separation of the 2,300,000 units issued in its underwritten initial public offering in accordance with their terms. […]
